Cynthia D O'Malley

Summary

Affiliation: Amgen Inc
Country: USA

Publications

  1. ncbi request reprint Multimorbidity in women with and without osteoporosis: results from a large US retrospective cohort study 2004-2009
    C D O'Malley
    Amgen Inc, MS ASF 2 1120 Veterans Blvd, South San Francisco, CA, 94080, USA
    Osteoporos Int 25:2117-30. 2014
  2. pmc Factors affecting receipt of chemotherapy in women with breast cancer
    Libby Morimoto
    Exponent Health Sciences, Menlo Park, CA, USA
    Int J Womens Health 2:107-22. 2010
  3. ncbi request reprint The implications of age and comorbidity on survival following epithelial ovarian cancer: summary and results from a Centers for Disease Control and Prevention study
    Cynthia D O'Malley
    Amgen Inc, One Amgen Center Drive, Thousand Oaks, CA 91320, USA
    J Womens Health (Larchmt) 21:887-94. 2012
  4. doi request reprint Trends in dual-energy X-ray absorptiometry in the United States, 2000-2009
    Cynthia D O'Malley
    Center for Observational Research, Amgen, Inc, South San Francisco, CA 94080, USA
    J Clin Densitom 14:100-7. 2011
  5. doi request reprint Surgical staging of early stage epithelial ovarian cancer: results from the CDC-NPCR ovarian patterns of care study
    Rosemary D Cress
    California Cancer Registry, Public Health Institute, Sacramento, CA, USA
    Gynecol Oncol 121:94-9. 2011
  6. doi request reprint Prevalence and incidence of comorbidities in elderly women with ovarian cancer
    Victoria M Chia
    Amgen Inc, Thousand Oaks, CA, USA
    Gynecol Oncol 129:346-52. 2013
  7. ncbi request reprint Patterns of chemotherapy use for women with ovarian cancer: a population-based study
    Rosemary D Cress
    California Cancer Registry and Division of Gynecologic Oncology, University of California at Davis Medical Center, Sacramento, CA, USA
    J Clin Oncol 21:1530-5. 2003
  8. ncbi request reprint Declining rates of osteoporosis management following fragility fractures in the U.S., 2000 through 2009
    Akhila Balasubramanian
    Center for Observational Research, Amgen Inc, One Amgen Center Drive, MS 24 2 A, Thousand Oaks, CA 91320
    J Bone Joint Surg Am 96:e52. 2014
  9. pmc Misclassification of incident conditions using claims data: impact of varying the period used to exclude pre-existing disease
    Robert I Griffiths
    Outcomes Insights, Inc, 340 North Westlake Blvd, Suite 200, Westlake Village, CA 91362, USA
    BMC Med Res Methodol 13:32. 2013

Collaborators

Detail Information

Publications9

  1. ncbi request reprint Multimorbidity in women with and without osteoporosis: results from a large US retrospective cohort study 2004-2009
    C D O'Malley
    Amgen Inc, MS ASF 2 1120 Veterans Blvd, South San Francisco, CA, 94080, USA
    Osteoporos Int 25:2117-30. 2014
    ..The overall comorbidity burden and health service utilization were greater in women with osteoporosis than in the controls...
  2. pmc Factors affecting receipt of chemotherapy in women with breast cancer
    Libby Morimoto
    Exponent Health Sciences, Menlo Park, CA, USA
    Int J Womens Health 2:107-22. 2010
    ..Patterns of care for metastatic breast cancer, for which no standard-of-care exists, were of particular interest...
  3. ncbi request reprint The implications of age and comorbidity on survival following epithelial ovarian cancer: summary and results from a Centers for Disease Control and Prevention study
    Cynthia D O'Malley
    Amgen Inc, One Amgen Center Drive, Thousand Oaks, CA 91320, USA
    J Womens Health (Larchmt) 21:887-94. 2012
    ..We report on this disparity and add further evidence about the relationship among age, comorbidity, and survival after ovarian cancer...
  4. doi request reprint Trends in dual-energy X-ray absorptiometry in the United States, 2000-2009
    Cynthia D O'Malley
    Center for Observational Research, Amgen, Inc, South San Francisco, CA 94080, USA
    J Clin Densitom 14:100-7. 2011
    ..Continuing to provide access to DXA testing for women at increased risk of osteoporosis is important to providing high-quality care for metabolic bone disease in the United States...
  5. doi request reprint Surgical staging of early stage epithelial ovarian cancer: results from the CDC-NPCR ovarian patterns of care study
    Rosemary D Cress
    California Cancer Registry, Public Health Institute, Sacramento, CA, USA
    Gynecol Oncol 121:94-9. 2011
    ....
  6. doi request reprint Prevalence and incidence of comorbidities in elderly women with ovarian cancer
    Victoria M Chia
    Amgen Inc, Thousand Oaks, CA, USA
    Gynecol Oncol 129:346-52. 2013
    ..Studies suggest comorbidity plays an important role in ovarian cancer. We characterized the epidemiology of comorbid conditions in elderly U.S. women with ovarian cancer...
  7. ncbi request reprint Patterns of chemotherapy use for women with ovarian cancer: a population-based study
    Rosemary D Cress
    California Cancer Registry and Division of Gynecologic Oncology, University of California at Davis Medical Center, Sacramento, CA, USA
    J Clin Oncol 21:1530-5. 2003
    ..To evaluate adherence to published recommendations for chemotherapy for ovarian cancer patients in the general community and to identify factors associated with its use...
  8. ncbi request reprint Declining rates of osteoporosis management following fragility fractures in the U.S., 2000 through 2009
    Akhila Balasubramanian
    Center for Observational Research, Amgen Inc, One Amgen Center Drive, MS 24 2 A, Thousand Oaks, CA 91320
    J Bone Joint Surg Am 96:e52. 2014
    ....
  9. pmc Misclassification of incident conditions using claims data: impact of varying the period used to exclude pre-existing disease
    Robert I Griffiths
    Outcomes Insights, Inc, 340 North Westlake Blvd, Suite 200, Westlake Village, CA 91362, USA
    BMC Med Res Methodol 13:32. 2013
    ..Using Medicare claims, we examined the impact of selecting shorter versus longer prevalence periods on the incidence and misclassification of 12 relatively common conditions in older persons...